![]() |
市場調查報告書
商品編碼
2046494
細胞農業市場-全球產業規模、佔有率、趨勢、機會和預測:按技術、應用、終端用戶產業、地區和競爭格局分類,2021-2031年Cellular Agriculture Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, By End User Industry, By Region & Competition, 2021-2031F |
||||||
全球細胞農業市場預計將經歷顯著成長,從 2025 年的 2.5901 億美元成長到 2031 年的 6.2552 億美元,複合年成長率為 15.83%。
在這個創新領域,肉類、乳製品和雞蛋等動物性食品直接透過細胞培養生產,繞過了傳統的畜牧養殖。推動這一市場擴張的關鍵因素包括:日益成長的人口迫切需要加強全球糧食安全;需要減少傳統畜牧養殖對環境造成的巨大影響;消費者對動物福利的日益關注;以及希望降低通用感染疾病的威脅。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 2.5901億美元 |
| 市場規模:2031年 | 6.2552億美元 |
| 複合年成長率:2026-2031年 | 15.83% |
| 成長最快的細分市場 | 細胞株 |
| 最大的市場 | 北美洲 |
然而,該行業面臨一個重大障礙:將生產規模擴大到工業化水平的高成本,使其目前無法在價格上與傳統肉類競爭。此外,諸如開發大規模生物反應器和建立穩定的培養基供應鏈等技術挑戰,也進一步限制了其廣泛的市場准入。根據良好食品研究所(Good Food Institute)的一份報告顯示,儘管全球資金籌措環境充滿挑戰,但培養肉和人造水產品公司在2024年仍獲得了1.39億美元的投資。解決這些資金和技術難題,對於該行業成功從初期研發階段過渡到全面商業化至關重要。
全球細胞農業市場的主要驅動力是人們對環境永續食品體係日益成長的需求。隨著應對氣候變遷成為全球優先事項,食品生產面臨著脫碳的壓力,而人造培養肉作為重要的替代方案,正日益受到關注,以減少傳統畜牧業帶來的大量溫室氣體排放和土地佔用。生命週期評估證實了這些環境效益,顯示與傳統方法相比,人造肉的資源消耗強度可以顯著降低。例如,2024年4月,良好食品研究所(Good Food Institute)報告稱,使用可再生能源生產的培養肉與傳統牛肉相比,碳足跡可減少92%,這可能成為國家淨零排放策略和企業永續發展計畫的潛在推動力。
與加速市場商業化和技術進步同等重要的是,擴大支持性法規結構和政府主導的措施。各國政府日益將細胞農業視為國家糧食主權的重要組成部分,因此撥出專款來降低此擴張階段的風險。一個典型的例子是,英國研究與創新署(UKRI)於2024年8月投資1,500萬英鎊,建立了國家研發中心,旨在加強英國國內產業。除了公共部門的支持外,私營部門也在積極行動。例如,像Mosa Meat這樣的公司,儘管面臨普遍的經濟挑戰,仍持續吸引投資。該公司於2024年4月籌集了4000萬歐元,為擴大生產和進入市場做準備。
全球細胞農業市場擴張的主要障礙在於將生產規模擴大到工業化水準的高成本。這項資金和技術障礙直接阻礙了生產商實現足夠低的單位成本,無法與傳統肉品在價格上競爭。此外,建造商業生物反應器需要大量的初始投資,而取得藥用級培養基的營運成本也居高不下,因此,培養肉目前仍主要是一種高階小眾產品,而非價格親民的大眾市場產品。因此,由於無法提供具有競爭力的消費者價格,抑制了市場需求,並限制了零售通路的拓展,該市場目前仍主要處於研發階段。
當比較現有投資資本與真正需要的基礎建設資金時,這種規模化難題的嚴重性便顯而易見。根據良好食品研究所(Good Food Institute)的報告顯示,自培養肉產業的累積私人投資額約為31億美元。考慮到建立足以與傳統農業在全球範圍內競爭的工業產能所需的資本密集度遠遠超過以往的投資水平,這一數額凸顯了嚴重的資金短缺。這種不平衡極大地阻礙了從試點規模設施向全面商業化營運的過渡,從而限制了潛在的市場成長率。
細胞農業的關鍵策略趨勢之一是將植物來源成分與培養動物細胞結合的混合產品商業化,旨在加速市場准入並解決現有的規模化生產瓶頸。生產商正日益開發含有少量培養動物細胞並將其與植物來源蛋白結合的產品。這種方法能夠有效生產出質地和風味與真肉相似的產品,同時大幅降低生產成本,使企業無需立即建造大規模工業生物反應器設施即可將面向消費者的產品推向市場。例如,良好食品研究所 (Good Food Institute) 發布的《2024 年行業現狀報告》重點介紹了 GOOD Meat 公司在新加坡推出的一款零售產品,該產品除植物來源成分外,僅使用 3% 的培養雞肉,展現了實現價格競爭力的切實可行的途徑。
同時,無血清培養基的廣泛應用正在徹底改變該領域的單位經濟效益,因為它消除了對昂貴動物性成分的需求。創新公司正積極推出特定的生化配方和先進的回收技術,以取代胎牛血清。牛歷來是細胞農業運作成本高的主要因素。這項技術進步對於實現成本效益至關重要,而成本效益是廣泛市場滲透所必需的。正如《食品導航》(Food Navigator)2024年9月的報導所詳述,使用無血清培養基和連續加工技術的研究預測,培養雞肉的生產成本將降至每磅約6.20美元,接近有機雞肉的價格水平。
The global cellular agriculture market is projected to experience substantial growth, increasing from USD 259.01 Million in 2025 to USD 625.52 Million by 2031, at a Compound Annual Growth Rate of 15.83%. This innovative field involves producing animal-derived foods like meat, dairy, and eggs directly from cell cultures, bypassing traditional livestock farming. Key drivers for this market's expansion include the critical need to bolster global food security for a growing population, the imperative to lessen the significant environmental footprint of conventional animal agriculture, increasing consumer emphasis on animal welfare, and the desire to diminish the threat of zoonotic diseases.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 259.01 Million |
| Market Size 2031 | USD 625.52 Million |
| CAGR 2026-2031 | 15.83% |
| Fastest Growing Segment | Cell Lines |
| Largest Market | North America |
Nevertheless, the sector faces a considerable hurdle in the high costs associated with scaling production to industrial capacities, which currently impedes achieving price competitiveness with conventional meat. Technical challenges in developing large-scale bioreactors and establishing robust supply chains for essential growth media further limit its broad market accessibility. Despite a challenging global funding environment, cultivated meat and seafood companies secured $139 million in investment during 2024, as reported by the Good Food Institute. Addressing these financial and technical obstacles is crucial for the industry to successfully transition from early-stage development to full commercial viability.
Market Driver
The global cellular agriculture market is primarily driven by the increasing demand for environmentally sustainable food systems. With climate change mitigation being a top global concern, food production faces pressure to decarbonize, making cell-based meat a vital alternative to traditional livestock farming's substantial greenhouse gas emissions and extensive land use. Life cycle assessments confirm this environmental benefit, showing the technology's capacity to significantly decrease resource intensity compared to conventional methods. For instance, the Good Food Institute reported in April 2024 that cultivated meat produced with renewable energy could reduce the carbon footprint by 92% compared to conventional beef, a potential driving national net-zero strategies and corporate sustainability plans.
Equally crucial for accelerating market commercialization and technical advancement is the proliferation of supportive regulatory frameworks and governmental initiatives. Governments are increasingly viewing cellular agriculture as a key component of national food sovereignty and are therefore allocating specific funding to mitigate risks during the sector's scaling phase. An illustrative example of this commitment is the £15 million investment by UK Research and Innovation in August 2024 to establish the National Alternative Protein Innovation Centre, aimed at strengthening the domestic industry. This public sector endorsement is complemented by ongoing private sector activity, as companies like Mosa Meat, which secured €40 million in April 2024 to scale production and prepare for market entry, continue to attract capital despite broader economic challenges.
Market Challenge
The primary impediment to the global cellular agriculture market's expansion is the high cost involved in scaling production to industrial capacities. This financial and technical barrier directly prevents manufacturers from achieving unit costs low enough to compete on price with conventional meat products. The substantial capital outlay for constructing commercial-grade bioreactors, coupled with the expensive operational costs of acquiring pharmaceutical-grade growth media, means cultivated meat largely remains a premium niche rather than an accessible mass-market commodity. As a result, the inability to offer competitive consumer pricing constrains demand and restricts retail access, keeping the market predominantly in its research and development stages.
The significant scope of this scaling difficulty becomes apparent when comparing available investment capital against the infrastructure funding truly necessary. As reported by the Good Food Institute, cumulative private investment in the cultivated meat sector since its inception reached approximately $3.1 billion by 2024. This amount underscores a critical funding shortfall, given that the capital intensity required to establish sufficient industrial capacity to compete globally with traditional agriculture far surpasses historical investment levels. This imbalance severely hampers the transition from pilot-scale facilities to comprehensive commercial operations, thereby limiting potential market growth rates.
Market Trends
A significant strategic trend in cellular agriculture is the commercialization of hybrid plant-cultivated meat products, designed to accelerate market entry and address existing scaling constraints. Producers are increasingly developing items that combine a small proportion of cultivated animal cells with plant-based proteins. This approach effectively creates products that offer the desired sensory experience of meat while substantially reducing production expenses, enabling companies to introduce consumer-ready goods without requiring full industrial-scale bioreactor capacity immediately. For example, the Good Food Institute's 2024 'State of the Industry' report highlighted GOOD Meat's launch of a Singapore retail product featuring only 3% cultivated chicken alongside plant ingredients, showcasing a practical route to price competitiveness.
Simultaneously, the widespread integration of serum-free growth media is revolutionizing the sector's unit economics by removing the need for costly animal-derived ingredients. Innovators are actively implementing specific biochemical formulations and advanced recycling techniques to replace fetal bovine serum, which has historically been a major contributor to the high operating costs in cellular agriculture. This technological advancement is crucial for realizing the cost efficiencies essential for achieving broad market adoption. As detailed in a September 2024 Food Navigator article, a study utilizing serum-free media and continuous processing projected that cultivated chicken production costs could decrease to approximately $6.20 per pound, approaching the price point of organic poultry.
Report Scope
In this report, the Global Cellular Agriculture Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Cellular Agriculture Market.
Global Cellular Agriculture Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: